药物科学制备,体外和体内研究维生素B12负载植入物Al-Rasheed大学学院,伊拉克

J. Faraj, Shaimaa M. Mohammed, Ihab I. Al-khalifa, Sabah Nema Al Thamer, K. A. Shareffi, P. P. Deluca
{"title":"药物科学制备,体外和体内研究维生素B12负载植入物Al-Rasheed大学学院,伊拉克","authors":"J. Faraj, Shaimaa M. Mohammed, Ihab I. Al-khalifa, Sabah Nema Al Thamer, K. A. Shareffi, P. P. Deluca","doi":"10.35248/2167-1052.19.9.230","DOIUrl":null,"url":null,"abstract":"Vitamin B12 is an important water-soluble vitamin which is found in a variety of food such as fish, shellfish, meat, and dairy products. It helps maintain healthy nerve cells and red blood cells, as well as aid in rapid DNA production during cell division. The daily requirement of vitamin B12 for the human body is approximately 1-25 µg . In 1960 introduced long-acting depot antipsychotic drug as the first long acting medications. Depot formulations providing further reductions in morbidity and mortality. Because they bypass the gastrointestinal tract, Depot treatments decrease the amount of medication needed and reduce certain peripheral side effects. Understanding the clinical and compliance of patients from the use of single dose with multiple and consecutive treatment of B12, we have developed long-term implantable medication delivery loaded with vitamin B12. The proposed method of controlled drug delivery uses sterile implants processed with a Poly (lactic-co-glycolic acid) (PLGA) polymer with a delivery interval of up to one month depending on polymer composition, and drug loading. In this study, 3 goals were addressed:  1: To formulate six different batches of biodegradable polymer implants loaded with vitamin 12 and target profile shown in Tables 1. 2: To characterize the formulated implants and establish an in vitro release for the B12 as a function of time. 3: Perform in vivo study and measure the serum concentration of B12 released from implants subcutaneously inserted into rats. Accomplishment of these three goals could provide the feasibility of controlled release vitamin B12 implants for human treatment for vitamin deficiency.","PeriodicalId":7385,"journal":{"name":"Advances in Pharmacoepidemiology and Drug Safety","volume":"121 3 1","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phama Sci Preparation, In Vitro and In Vivo Studies of Vitamin B12 Loaded Implants Al-Rasheed University College, Iraq\",\"authors\":\"J. Faraj, Shaimaa M. Mohammed, Ihab I. Al-khalifa, Sabah Nema Al Thamer, K. A. Shareffi, P. P. Deluca\",\"doi\":\"10.35248/2167-1052.19.9.230\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Vitamin B12 is an important water-soluble vitamin which is found in a variety of food such as fish, shellfish, meat, and dairy products. It helps maintain healthy nerve cells and red blood cells, as well as aid in rapid DNA production during cell division. The daily requirement of vitamin B12 for the human body is approximately 1-25 µg . In 1960 introduced long-acting depot antipsychotic drug as the first long acting medications. Depot formulations providing further reductions in morbidity and mortality. Because they bypass the gastrointestinal tract, Depot treatments decrease the amount of medication needed and reduce certain peripheral side effects. Understanding the clinical and compliance of patients from the use of single dose with multiple and consecutive treatment of B12, we have developed long-term implantable medication delivery loaded with vitamin B12. The proposed method of controlled drug delivery uses sterile implants processed with a Poly (lactic-co-glycolic acid) (PLGA) polymer with a delivery interval of up to one month depending on polymer composition, and drug loading. In this study, 3 goals were addressed:  1: To formulate six different batches of biodegradable polymer implants loaded with vitamin 12 and target profile shown in Tables 1. 2: To characterize the formulated implants and establish an in vitro release for the B12 as a function of time. 3: Perform in vivo study and measure the serum concentration of B12 released from implants subcutaneously inserted into rats. Accomplishment of these three goals could provide the feasibility of controlled release vitamin B12 implants for human treatment for vitamin deficiency.\",\"PeriodicalId\":7385,\"journal\":{\"name\":\"Advances in Pharmacoepidemiology and Drug Safety\",\"volume\":\"121 3 1\",\"pages\":\"1-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Pharmacoepidemiology and Drug Safety\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/2167-1052.19.9.230\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Pharmacoepidemiology and Drug Safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2167-1052.19.9.230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

维生素B12是一种重要的水溶性维生素,存在于鱼类、贝类、肉类和乳制品等多种食物中。它有助于维持健康的神经细胞和红细胞,以及在细胞分裂过程中帮助快速生成DNA。人体每天所需的维生素B12约为1-25微克。1960年推出长效库抗精神病药作为第一批长效药物。仓库配方提供进一步降低发病率和死亡率。由于它们绕过胃肠道,Depot治疗减少了所需的药物量并减少了某些外围副作用。了解患者使用单剂量多次连续治疗的临床依从性,我们开发了长期植入的维生素B12药物输送。所提出的受控药物递送方法使用用聚乳酸-羟基乙酸(PLGA)聚合物处理的无菌植入物,根据聚合物组成和药物负载的不同,递送间隔可达一个月。在这项研究中,有3个目标:1:配制6个不同批次的可生物降解聚合物植入物,装载维生素12,目标谱如表1所示。2:表征配方植入物,并建立B12的体外释放作为时间的函数。3:进行体内研究,测定大鼠皮下植入物释放的血清B12浓度。这三个目标的实现为控释维生素B12植入物治疗人体维生素缺乏症提供了可行性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Phama Sci Preparation, In Vitro and In Vivo Studies of Vitamin B12 Loaded Implants Al-Rasheed University College, Iraq
Vitamin B12 is an important water-soluble vitamin which is found in a variety of food such as fish, shellfish, meat, and dairy products. It helps maintain healthy nerve cells and red blood cells, as well as aid in rapid DNA production during cell division. The daily requirement of vitamin B12 for the human body is approximately 1-25 µg . In 1960 introduced long-acting depot antipsychotic drug as the first long acting medications. Depot formulations providing further reductions in morbidity and mortality. Because they bypass the gastrointestinal tract, Depot treatments decrease the amount of medication needed and reduce certain peripheral side effects. Understanding the clinical and compliance of patients from the use of single dose with multiple and consecutive treatment of B12, we have developed long-term implantable medication delivery loaded with vitamin B12. The proposed method of controlled drug delivery uses sterile implants processed with a Poly (lactic-co-glycolic acid) (PLGA) polymer with a delivery interval of up to one month depending on polymer composition, and drug loading. In this study, 3 goals were addressed:  1: To formulate six different batches of biodegradable polymer implants loaded with vitamin 12 and target profile shown in Tables 1. 2: To characterize the formulated implants and establish an in vitro release for the B12 as a function of time. 3: Perform in vivo study and measure the serum concentration of B12 released from implants subcutaneously inserted into rats. Accomplishment of these three goals could provide the feasibility of controlled release vitamin B12 implants for human treatment for vitamin deficiency.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Antidepressant: An Overview Quantification of 3?-Acetyl-11-Keto-?-Boswellic Acid and 11-Keto-?Boswellic Acid in the Resin of Boswellia species by HPTLC The Use of 3D Models to Test Potential Anti-SARS-CoV-2 Drugs and Infection Mechanisms Local Drug Delivery in Periodontal Therapy: A Contemporary Review Challenges of Hepatotoxicity Associated with Isoniazid Preventive Therapy among People Living with HIV in Eritrea
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1